Description
Difenda (Drospirenone, Ethinyl Estradiol) Coated Tablets 3 mg/0.02 mg. №28
Ingredients
Each coated tablet contains 3 mg of drospirenone and 0.02 mg of ethinyl estradiol.
Mechanism of Action
Difenda tablets work by inhibiting ovulation and altering cervical mucus consistency, providing reliable pregnancy prevention.
Pharmacological Properties
The combination of drospirenone and ethinyl estradiol in Difenda tablets offers contraceptive effects and therapeutic benefits due to drospirenone’s anti-androgenic properties and ethinyl estradiol’s synthetic estrogen composition.
Indications for Use
Difenda tablets are indicated for the prevention of pregnancy. They are also used to treat moderate acne in women seeking oral contraception.
Contraindications
Avoid using Difenda if pregnant or breastfeeding. It is contraindicated in women with a history of blood clots, certain cancers, liver disease, or uncontrolled high blood pressure.
Side Effects
Common side effects of Difenda may include nausea, breast tenderness, headache, and breakthrough bleeding. Contact your healthcare provider if you experience severe side effects.
Usage Instructions
Take one tablet daily at the same time each day, with or without food. Follow the instructions on the package for the correct order to take the tablets.
Benefits Compared to Analogues
Difenda has shown high contraceptive efficacy with a low incidence of side effects compared to other contraceptive options. It may also offer additional benefits such as improvement in acne symptoms and menstrual cycle regularity.
Suitable Patient Groups
Difenda is suitable for adult women of reproductive age. Consult a healthcare provider for use in specific patient populations such as adolescents, elderly individuals, or those with underlying medical conditions.
Storage and Shelf Life
Store Difenda in a cool, dry place away from direct sunlight. Check the expiration date on the packaging and do not use the product beyond the stated shelf life.
Packaging Description
Difenda is available in packs containing 28 coated tablets. The packaging is designed to protect the tablets from environmental factors and maintain their integrity.
Scientific Evidence
Difenda tablets containing drospirenone and ethinyl estradiol have been extensively studied for their contraceptive efficacy and safety profile. Clinical trials have demonstrated high contraceptive effectiveness with a low incidence of side effects. Research has shown that the combination of drospirenone and ethinyl estradiol provides reliable pregnancy prevention by inhibiting ovulation and altering cervical mucus consistency.
Moreover, studies have indicated that Difenda may offer additional benefits beyond contraception, such as improvement in acne symptoms and menstrual cycle regularity. The pharmacological actions of drospirenone, a progestin with anti-androgenic properties, combined with ethinyl estradiol, a synthetic estrogen, contribute to the drug’s contraceptive effects and other therapeutic benefits.
